{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:34:45Z","timestamp":1792193685714,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.steroids.2013.04.011","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T21:05:55Z","timestamp":1366923955000},"page":"751-754","source":"Crossref","is-referenced-by-count":33,"title":["Diagnosis of adolescent polycystic ovary syndrome"],"prefix":"10.1016","volume":"78","author":[{"given":"Tristan S.E.","family":"Hardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2013.04.011_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpag.2009.04.004","article-title":"Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome","volume":"23","author":"Bekx","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.steroids.2013.04.011_b0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.fertnstert.2010.06.015","article-title":"Polycystic ovarian morphology in postmenarchal adolescents","volume":"95","author":"Codner","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.011_b0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jadohealth.2008.05.004","article-title":"Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls","volume":"43","author":"Biro","year":"2008","journal-title":"J Adol Health"},{"issue":"6","key":"10.1016\/j.steroids.2013.04.011_b0020","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.steroids.2013.04.011_b0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.steroids.2013.04.011_b0030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2013.04.011_b0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MOP.0b013e328236743f","article-title":"Polycystic ovary syndrome update in adolescence","volume":"19","author":"Hassan","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.steroids.2013.04.011_b0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jpag.2012.03.004","article-title":"NASPAG Research Committee. Clinical Variability in Approaches to Polycystic Ovary Syndrome","volume":"25","author":"Bonny","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.steroids.2013.04.011_b0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpag.2009.10.004","article-title":"Insulin resistance and adolescent girls with polycystic ovary syndrome","volume":"23","author":"Bhattacharya","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"10.1016\/j.steroids.2013.04.011_b0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpag.2005.05.006","article-title":"Insulin resistance in adolescents with menstrual irregularities","volume":"18","author":"Fernandes","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.steroids.2013.04.011_b0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.fertnstert.2012.08.025","article-title":"Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome","volume":"98","author":"Trottier","year":"2012","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.steroids.2013.04.011_b0060","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1447-0756.2010.01516.x","article-title":"Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 \u2018joint interim criteria\u2019","volume":"37","author":"Bhattacharya","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"10.1016\/j.steroids.2013.04.011_b0065","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jpeds.2012.11.019","article-title":"Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents","volume":"162","author":"Roe","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.steroids.2013.04.011_b0070","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/jc.2008-1198","article-title":"Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome","volume":"93","author":"Rossi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.steroids.2013.04.011_b0075","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4274\/jcrpe.v1i4.50","article-title":"Evaluation of adolescents for polycystic ovary syndrome in an urban population","volume":"1","author":"Broder-Fingert","year":"2009","journal-title":"J Clin Res Ped Endocrinol"},{"key":"10.1016\/j.steroids.2013.04.011_b0080","doi-asserted-by":"crossref","first-page":"201.e1-5","DOI":"10.1016\/j.ajog.2010.03.008","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"203","author":"Carmina","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.steroids.2013.04.011_b0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/humrep\/der396","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS)","volume":"27","author":"The Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","year":"2012","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.steroids.2013.04.011_b0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/humrep\/deh079","article-title":"Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years","volume":"19","author":"van Hooff","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2013.04.011_b0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpag.2010.06.003","article-title":"Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought","volume":"24","author":"Bronstein","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5\u20136","key":"10.1016\/j.steroids.2013.04.011_b0100","first-page":"459","article-title":"Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome","volume":"25","author":"Carroll","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.011_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpag.2007.01.001","article-title":"Polycystic ovary syndrome in adolescents","volume":"20","author":"Khan","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.steroids.2013.04.011_b0110","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1210\/jc.2006-0835","article-title":"Functional significance of polycystic-size ovaries in healthy adolescents","volume":"91","author":"Mortensen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.011_b0115","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2009-0839","article-title":"Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age","volume":"94","author":"Alsamarai","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.steroids.2013.04.011_b0120","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/der102","article-title":"Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis","volume":"26","author":"Hickey","year":"2011","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.steroids.2013.04.011_b0125","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1093\/humrep\/deq273","article-title":"A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?","volume":"25","author":"Kristensen","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2013.04.011_b0130","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.steroids.2013.04.011_b0135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpag.2008.01.081","article-title":"The role of ovarian volume as a diagnostic criterion for chinese adolescents with polycystic ovary syndrome","volume":"21","author":"Chen","year":"2008","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"10.1016\/j.steroids.2013.04.011_b0140","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/humrep\/det062","article-title":"Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume","volume":"28","author":"Lujan","year":"2013","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.steroids.2013.04.011_b0145","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.fertnstert.2005.04.039","article-title":"Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study","volume":"84","author":"Yoo","year":"2005","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.steroids.2013.04.011_b0150","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/humrep\/del161","article-title":"The role of three-dimensional ultrasonography in polycystic ovary syndrome","volume":"21","author":"Lam","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2013.04.011_b0155","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS society. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.011_b0160","unstructured":"National Institutes of Health. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome: prevention.nih.gov\/workshops\/2012\/pcos\/, (accessed 6th April 2013)."},{"key":"10.1016\/j.steroids.2013.04.011_b0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jpag.2004.01.005","article-title":"Clinical and metabolic findings in adolescent females with hyperandrogenism","volume":"17","author":"Huppert","year":"2004","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.steroids.2013.04.011_b0170","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.fertnstert.2008.06.004","article-title":"Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels","volume":"92","author":"Fruzzetti","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.011_b0175","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.fertnstert.2011.03.001","article-title":"Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome","volume":"95","author":"Hart","year":"2011","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.steroids.2013.04.011_b0180","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1093\/humrep\/des309","article-title":"Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study","volume":"27","author":"Pinola","year":"2012","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.steroids.2013.04.011_b0185","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Clinical review: identifying children at risk for polycystic ovary syndrome","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.steroids.2013.04.011_b0190","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.steroids.2013.04.011_b0195","first-page":"45","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"4","author":"Roe","year":"2011","journal-title":"Rev Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.steroids.2013.04.011_b0200","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/humrep\/der223","article-title":"Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone","volume":"26","author":"Villarroel","year":"2011","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.steroids.2013.04.011_b0205","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1933719111424444","article-title":"Relationship between anti-Mullerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome","volume":"19","author":"Sir-Petermann","year":"2012","journal-title":"Reprod Sci"},{"key":"10.1016\/j.steroids.2013.04.011_b0210","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.fertnstert.2005.02.052","article-title":"Serum mullerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome","volume":"84","author":"Siow","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.011_b0215","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1210\/jc.2007-0267","article-title":"Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome","volume":"92","author":"Crisosto","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2013.04.011_b0220","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2013.04.011_b0225","series-title":"Novel Insights into the Pathophysiology and Treatment of PCOS","first-page":"122","article-title":"Polycystic ovary syndrome: prognosis and risk of comorbidity","author":"Hardy","year":"2013"},{"issue":"2","key":"10.1016\/j.steroids.2013.04.011_b0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.steroids.2013.04.011_b0235","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","article-title":"Comparative study of the effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drosperinone in patients with polycystic ovary syndrome","volume":"98","author":"Bhattacharya","year":"2012","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.steroids.2013.04.011_b0240","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2265.2000.00982.x","article-title":"Spironolactone as a single agent for long-term therapy of hirsute patients","volume":"52","author":"Spritzer","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.steroids.2013.04.011_b0245","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"7","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.steroids.2013.04.011_b0250","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1210\/jc.2011-1609","article-title":"Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls","volume":"96","author":"Lass","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.steroids.2013.04.011_b0255","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1210\/jc.2011-2520","article-title":"Management of adolescents with polycystic ovary syndrome","volume":"96","author":"Freemark","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.steroids.2013.04.011_b0260","doi-asserted-by":"crossref","first-page":"E1262","DOI":"10.1210\/jc.2011-0555","article-title":"Early metformin therapy (age 8\u201312 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhoea in adolescence","volume":"96","author":"Ibanez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.steroids.2013.04.011_b0265","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jc.87.5.2013","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X13000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X13000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T15:24:18Z","timestamp":1539703458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X13000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0039128X13000937"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2013.04.011","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}